Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
This trial is a prospective, randomized, multicenter, multinational, blinded, superiority trial. The objective of this trial is to evaluate the effectiveness of left atrial appendage exclusion (LAAE) for the prevention of ischemic stroke or systemic arterial embolism in subjects undergoing cardiac surgery who have risk factors for atrial fibrillation and ischemic stroke.
Location: SIMR (Sacramento/Valley Area)
Please contact: SIMR@sutterhealth.org about LeAAPS
Principal Investigator
Related Studies
Stupski Serious Illness Program Evaluation
Investigator: Sylvia Sudat, PhD
The Impact of Smoking, Comorbidities, and Race/Ethnicity on COVID-19 Infection and Disease Severity
Investigator: Jiang Li, Ph.D., MPH
Statin Use and Risk Prediction of Atherosclerotic Cardiovascular Disease in Minority Subgroups (SURPASS) Study
Investigators: Jiang Li, Ph.D., MPH, External PI, Principal Investigator
HOMBRE (Hombres con Opciones para Mejorar el Bienestar y bajar el Riesgo de Enfermedades crónicas)
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Prevalence, Treatment and Outcomes of Asian Subgroups with Coronary Artery Disease in the U.S.
Investigators: External PI, Principal Investigator, Jiang Li, Ph.D., MPH
Cardiovascular Disease Among Asians and Pacific Islanders (CASPER)
Investigators: External PI, Principal Investigator, Jiang Li, Ph.D., MPH
Advance Care Planning Practices in Caring for Vulnerable Elders with Multiple Chronic Conditions
Culturally Adapted DPP [Diabetes Prevention Program] Intervention for Mexican Americans in Primary Care: An RCT [randomized controlled trial]
Research Aimed at Improving Both Mood and Weight (RAINBOW)
International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)
Investigator: Bob S. Hu, M.D.